0001179110-21-000986.txt : 20210129 0001179110-21-000986.hdr.sgml : 20210129 20210129191002 ACCESSION NUMBER: 0001179110-21-000986 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210127 FILED AS OF DATE: 20210129 DATE AS OF CHANGE: 20210129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dummer Wolfgang CENTRAL INDEX KEY: 0001749991 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29889 FILM NUMBER: 21573549 MAIL ADDRESS: STREET 1: 5491 OPTICAL CT. CITY: SAN JOSE STATE: CA ZIP: 95138 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RIGEL PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001034842 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943248524 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1180 VETERANS BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 MAIL ADDRESS: STREET 1: 1180 VETERANS BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 edgar.xml FORM 4 - X0306 4 2021-01-27 0 0001034842 RIGEL PHARMACEUTICALS INC RIGL 0001749991 Dummer Wolfgang C/O RIGEL PHARMACEUTICALS, INC. 1180 VETERANS BLVD. SOUTH SAN FRANCISCO CA 94080 0 1 0 0 EVP & CMO Stock Option(right to buy) 3.54 2021-01-27 4 A 0 125000 0 A 2031-01-27 Common Stock 125000 125000 D Stock Option (right to buy) 2.38 2021-01-27 4 A 0 37500 0 A 2030-08-25 Common Stock 37500 37500 D The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2021, subject to the reporting person's continuous service to the issuer through each such period. The reporting person was granted a performance-based option to purchase 37,500 shares of common stock on August 25, 2020. Thus, the exercise price of this option is $2.38 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On January 27, 2021, it was determined that the performance metric had been met. The shares of common stock subject to the option vest in equal monthly installments over twenty-four (24) months from the vesting commencement date of December 18, 2020, subject to the reporting person's continuous service to the issuer through each such period. /s/ Dolly Vance (Attorney-in-Fact) 2021-01-28